Valuation: Sanofi

Capitalization 97.83B 115B 90.12B 85.07B 159B 10,747B 162B 1,060B 415B 5,163B 433B 424B 18,333B P/E ratio 2026 *
11.9x
P/E ratio 2027 * 10.9x
Enterprise value 109B 128B 99.96B 94.37B 176B 11,920B 179B 1,175B 460B 5,727B 480B 470B 20,335B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.12x
Free-Float
87.31%
Yield 2026 *
5.25%
Yield 2027 * 5.58%
1 day+2.03%
1 week+0.63%
Current month-2.06%
1 month+6.06%
3 months-1.85%
6 months-3.48%
Current year-2.06%
1 week 78.83
Extreme 78.83
81.6
1 month 75.33
Extreme 75.33
83.77
Current year 74.85
Extreme 74.85
84.97
1 year 74.85
Extreme 74.85
98.36
3 years 74.85
Extreme 74.85
110.88
5 years 74.85
Extreme 74.85
110.88
10 years 62.5
Extreme 62.5
110.88
Manager TitleAgeSince
Chief Executive Officer 61 2026-02-16
Director of Finance/CFO 63 2024-03-31
Chief Operating Officer 41 2023-09-30
Director TitleAgeSince
Director/Board Member 72 2014-04-30
Director/Board Member 60 2019-04-29
Director/Board Member 56 2020-04-27
Name Varia. Jan 1. Weight AuM
+3.18%3.66% 158 M€
Change 5d. change 1-year change 3-years change Capi.($)
+2.03%+0.63%-11.82%-20.60% 112B
-0.76%-0.92%+22.29%+146.18% 832B
+0.90%+0.71%+55.55%+44.78% 573B
+1.84%+1.88%+17.40%+30.12% 365B
-0.35%-0.75%+29.45%+14.12% 322B
-0.47%-2.60%+49.06%+25.19% 313B
-0.16%+0.57%+51.52%+4.03% 297B
-0.28%-2.37%+39.71%+38.08% 292B
+0.32%+2.45%+22.72%+39.58% 189B
+1.02%+0.23%+35.53%+68.67% 173B
Average +0.26%-1.45%+31.14%+39.01% 346.72B
Weighted average by Cap. +0.05%-1.63%+33.90%+57.69%

Financials

2026 *2027 *
Net sales 46.65B 55.04B 42.97B 40.56B 75.74B 5,124B 77.11B 505B 198B 2,462B 207B 202B 8,741B 49.55B 58.46B 45.64B 43.09B 80.45B 5,443B 81.9B 537B 210B 2,615B 219B 215B 9,285B
Net income 8.74B 10.31B 8.05B 7.6B 14.18B 960B 14.44B 94.63B 37.03B 461B 38.68B 37.87B 1,637B 9.47B 11.17B 8.72B 8.24B 15.38B 1,040B 15.65B 103B 40.14B 500B 41.93B 41.05B 1,775B
Net Debt 10.68B 12.61B 9.84B 9.29B 17.35B 1,174B 17.66B 116B 45.29B 564B 47.31B 46.31B 2,002B 7.06B 8.33B 6.5B 6.14B 11.46B 775B 11.67B 76.45B 29.92B 372B 31.25B 30.59B 1,323B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-04-14 81.02 +2.03% 2,385,040
26-04-13 79.41 -0.97% 1,740,000
26-04-10 80.19 -0.90% 2,027,807
26-04-09 80.92 +0.06% 2,905,738
26-04-08 80.87 +0.45% 4,090,098
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
81.02EUR
Average target price
96.18EUR
Spread / Average Target
+18.71%

Quarterly revenue - Rate of surprise